Mankind Pharma Limited IPO Message Board (Page 62)

Mankind Pharma IPO
Is a 100% OFS

Unless the sellers leave enough on the table for the incoming new investors ... serious FII QIB buyers will not evidence any interest.

Hence in this IPO the ANCHOR INVESTORS LIST will be watched with a significantly greater interest.

THE MOST RELIABLE
List of Mainboard IPOs IN THE PIPELINE
(Status as on 01st April 2023)

A) DRHP Filed – SEBI Approval *Overdue*: DRHP filed >120 Days ago

1) EbixCash >>> DRHP filing date 10-Mar-22
2) WAPCOS >>> DRHP filing date 26-Sep-22
3) Tata Play >>> DRHP filing date 01-Dec-22
4) Indegene >>> DRHP filing date 16-Dec-22

B) DRHP Filed – SEBI Approval *Awaited*: DRHP filed <120 Days ago

5) Gandhar Oil Refinery (India) >>> DRHP filing date 23-Dec-22
6) Survival Technologies >>> DRHP filing date 30-Dec-22
7) Honasa Consumer >>> DRHP filing date 30-Dec-22
8) Ratnaveer Precision Engineering >>> DRHP filing date 27-Jan-23
9) Ideaforge Technology >>> DRHP filing date 13-Feb-23
10) AKME Fintrade (India) >>> DRHP filing date 16-Feb-23
11) Nova Agritech >>> DRHP filing date 06-Mar-23
12) TATA Technologies >>> DRHP filing date 10-Mar-23
13) SBFC Finance >>> DRHP filing date 23-Mar-23
14) Motisons Jewellers >>> DRHP filing date 27-Mar-23
15) Netweb Technologies India >>> DRHP filing date 29-Mar-23
16) SPC Life Sciences >>> DRHP filing date 29-Mar-23
17) Oravel Stays >>> DRHP filing date 31-Mar-23
18) Updater Services >>> DRHP filing date 31-Mar-23
19) Samhi Hotels >>> DRHP filing date 31-Mar-23
20) Aeroflex Industries >>> DRHP filing date 31-Mar-23
21) Pyramid Technoplast >>> DRHP filing date 31-Mar-23
22) Go Digit General Insurance >>> DRHP filing date 31-Mar-23

C) SEBI Approval *Received (<4 months ago)*:

1) Rashi Peripherals >>> SEBI Approval 31-Mar-23
2) Healthvista India >>> SEBI Approval 31-Mar-23
3) Cyient DLM >>> SEBI Approval 29-Mar-23
4) Zaggle Prepaid Ocean Services >>> SEBI Approval 29-Mar-23
5) J.G.Chemicals >>> SEBI Approval 20-Mar-23
6) IndiaFirst Life Insurance Company >>> SEBI Approval 15-Mar-23
7) R & B infra-Project >>> SEBI Approval 03-Mar-23
8) FirstMeridian Business Services >>> SEBI Approval 24-Feb-23
9) Lohia Corp >>> SEBI Approval 24-Feb-23
10) IRM Energy >>> SEBI Approval 21-Feb-23
11) Rishabh Instruments >>> SEBI Approval 17-Feb-23
12) Go Digit General Insurance >>> SEBI Approval 30-Jan-23
13) Balaji Solutions >>> SEBI Approval 23-Jan-23
14) Enviro Infra Engineers >>> SEBI Approval 23-Jan-23
15) Innova Captab >>> SEBI Approval 11-Jan-23
16) Blue Jet Healthcare >>> SEBI Approval 09-Jan-23
17) IKIO Lighting >>> SEBI Approval 16-Dec-22
18) Allied Blenders and Distillers >>> SEBI Approval 16-Dec-22

D) SEBI Approval *Received (<7 months ago)*:

19) Snapdeal >>> SEBI Approval 08-Dec-22
20) Manoj Vaibhav Gems N Jewellers >>> SEBI Approval 02-Dec-22
21) Concord Biotech >>> SEBI Approval 28-Nov-22
22) Signature Global (India) >>> SEBI Approval 24-Nov-22
23) Protean eGov Technologies >>> SEBI Approval 17-Nov-22
24) Yatra Online >>> SEBI Approval 17-Nov-22
25) Balaji Speciality Chemicals >>> SEBI Approval 15-Nov-22
26) Sai Silk Kalamandir >>> SEBI Approval 07-Nov-22
27) Utkarsh Small Finance Bank >>> SEBI Approval 21-Oct-22
 
E) SEBI Approval *Received (<12 months ago)*:

28) Hemani Industries >>> SEBI Approval 13-Oct-22
29) Plaza Wires >>> SEBI Approval 12-Oct-22
30) BIBA Fashions >>> SEBI Approval 11-Oct-22
31) Mitsu Chem Plast >>> SEBI Approval 11-Oct-22
32) Deltatech Gaming >>> SEBI Approval 30-Sep-22
33) Pristine Logistics and Infraprojects >>> SEBI Approval 30-Sep-22
34) Mukka Proteins >>> SEBI Approval 27-Sep-22
35) Gold Plus Glass Industry >>> SEBI Approval 23-Sep-22
36) Navi Technologies >>> SEBI Approval 05-Sep-22
37) Concord Enviro Systems >>> SEBI Approval 30-Aug-22
38) Prasol Chemicals >>> SEBI Approval 23-Aug-22
39) Vikram Solar >>> SEBI Approval 10-Aug-22
40) Yatharth Hospital & Trauma Care Services >>> SEBI Approval 02-Aug-22
41) PKH Ventures >>> SEBI Approval 22-Jul-22
42) Gujarat Polysol Chemicals >>> SEBI Approval 18-Jul-22
43) HMA Agro Industries >>> SEBI Approval 07-Jul-22
44) Senco Gold >>> SEBI Approval 05-Jul-22
45) Corrtech International >>> SEBI Approval 01-Jul-22
46) India Exposition Mart >>> SEBI Approval 16-Jun-22
47) Bharat FIH >>> SEBI Approval 10-Jun-22
48) Cogent E-Services >>> SEBI Approval 23-May-22
49) Macleods Pharmaceuticals >>> SEBI Approval 20-May-22
50) TBO TEK >>> SEBI Approval 19-May-22
51) Suraj Estate Developers >>> SEBI Approval 17-May-22
52) Fedbank Financial Services >>> SEBI Approval 13-May-22
53) Aadhar Housing Finance >>> SEBI Approval 05-May-22
54) Kids Clinic India >>> SEBI Approval 04-May-22
55) TVS Supply Chain Solutions >>> SEBI Approval 04-May-22
56) Imagine Marketing >>> SEBI Approval 30-Apr-22
57) FabIndia >>> SEBI Approval 30-Apr-22
58) Capillary Technologies India >>> SEBI Approval 30-Apr-22
59) Sanathan Textiles >>> SEBI Approval 30-Apr-22
60) Asianet Satellite Communications >>> SEBI Approval 30-Apr-22

F) SEBI Approval *Received (>12 months ago)*:

61) Maini Precision Products >>> SEBI Approval 17-Mar-22
62) Sresta Natural Bioproducts >>> SEBI Approval 15-Mar-22
63) Hexagon Nutrition >>> SEBI Approval 04-Mar-22
64) JK Files & Engineering >>> SEBI Approval 23-Feb-22
65) API Holdings >>> SEBI Approval 17-Feb-22
66) Wellness Forever Medicare >>> SEBI Approval 16-Feb-22
67) CMR Green Technologies >>> SEBI Approval 16-Feb-22
68) Capital Small Finance Bank >>> SEBI Approval 08-Feb-22
69) Jesons Industries >>> SEBI Approval 08-Feb-22
70) Waaree Energies >>> SEBI Approval 03-Jan-22
71) GPT Healthcare >>> SEBI Approval 29-Dec-21
72) Veeda Clinical Research >>> SEBI Approval 21-Dec-21
73) Sahajanand Medical Technologies >>> SEBI Approval 17-Dec-21
74) Le Travenues Technology >>> SEBI Approval 16-Dec-21
75) Keventer Agro >>> SEBI Approval 16-Dec-21
76) Emcure Pharmaceuticals >>> SEBI Approval 08-Dec-21
77) ESDS Software Solutions >>> SEBI Approval 03-Dec-21
78) Sterlite Power Transmissions >>> SEBI Approval 02-Dec-21

Guys I have received the information on gmp of rs 56 please rectify

68

Mankind Pharma IPO

GMP 72 +/- 2
Last heard

Mankind Pharma has mentioned ‘Dabur’ as their peer in DRHP.
What products do they both have in common? ‘Flavoured Products’? 😂😂
Sorry but didn’t understand the reason for adding ‘Dabur’.

bov badha mota loko ni gantri ma aapde khovai jai....

hamna grey market na jo premium 50 adi jai ane ipo na 1st day sudhi 40 thi 60 vache reh ne to retail ma y 2 pati no maal aave... shni ma tagdu allotment aave... etle badhu hadve hadve.... best suggetion aapu...

BHNI subject to ma vechvi best... baki mathu dukhi jase premium uchu nichu thase ne to... ane 100% maal malv no chance chhe means 2 peti no to confirm gano pan baki nu premium down hoy to 3 4 ke 10 peti y aavi sake...

retail ma pan cheela 6 mahina thi high ma high 3 to 5 lakh app ayi chhe.. to ama pan vadhi ne 10 thi 12 lakh ave e pan premium 100 etle 10% ryu to.. baki dhabbo narayan...

shni harsha ma 63000 aveli e pan ucha premiun e atyare mankind ma 70 P e mand mand 15k to 20k aave ane emay premium 50 niche jai etle 100% maal lagva na chance.

vaate vaate ane premium ni uch nich ma gantri badlase... dhime dhime pagla bharto chal morlo pagla bharto chaal...

Khub saras ganit samjavyu mota bhai tame.
Thank you

GOOD PREDICTION

"Mankind IPO" usi "man" ko aayega jo "kind" hoga... So please be kind with everyone here.. :)
I feel this will more or less behave like "MEDANTA". People will mostly have MIXED Views and ultimately it will reward investors. Let's see!

That depends upon the subscription figures and broader markets. But this should reward investors for sure.
In general, mainline IPOs are performing after weaker hands are out. You can check the movement of recently listed 2-3 main line IPOs to understand what I'm saying.

Yes. Will keep a track in it post listing.

After longtime eagle eye comeback😄

Mankind Pharma IPO – *GMP Estimated*

GMP 68 +/- 2

Mankind Pharma IPO – *GMP Estimated*

GMP 58 +/- 2

Mankind Pharma IPO

For FY 23-24 *HOS*

Expected:
PAT = 1,925Crs
EPS = 48.05

Forward P/E = 22.50X (at issue price of 1,080)

Mankind Pharma IPO – *GMP Estimated*

GMP 62 +/- 2

Mankind Pharma IPO – Financial Information (Basis of Valuation)

The information is collated from the following documents:
1) DRHP = Draft Red Herring Prospectus Dated September 15, 2022 (548 pages)

EPS for FY19-20 >>> Rs.25.72 (Page #158 of DRHP)
EPS for FY20-21 >>> Rs.31.59 (Page #158 of DRHP)
EPS for FY21-22 >>> Rs.35.78 (Page #158 of DRHP)

RoNW for FY19-20 >>> 29.56% (Page #159 of DRHP)
RoNW for FY20-21 >>> 26.80% (Page #159 of DRHP)
RoNW for FY21-22 >>> 23.29% (Page #159 of DRHP)

NAV as on 31st March 2022, was Rs.153.65 (Page #159 of DRHP)

Listed Industry Peer Group (Page #159 of DRHP): Sun Pharmaceuticals Industries, Cipla, Zydus Lifesciences, Torrent Pharmaceutical, Alkem, JB Chemicals & Pharmaceuticals, Eris Lifesciences, Ipca Laboratories, Abbott India, Glaxosmithkline Pharmaceuticals, Dabur India, Procter & Gamble Health, Zydus Wellness

Mankind Pharma IPO – Issue Information *(Tentative)*

Issue Opens on: 21st April 2023
Issue Closes on: 25th April 2023
Issue Type: Book Built Issue IPO
Issue Size: 4,00,58,844 Shares
Face Value: Re.1/- per Share
Issue Price: Rs.1060 – Rs1080 Share
Discount: NIL
Market Lot: 13 Shares
Listing At: NSE, BSE

Equity Shares outstanding prior to the Issue = 40,05,88,440 Shares
Fresh Issue of NIL Shares @1,080/- = Rs.NIL Crs
Offer for Sale of 4,00,58,844 Shares @1,080/- = Rs.4,326.36Crs
Equity Shares outstanding after the Issue = 40,05,88,440 Shares

Category-wise Break up:
Anchor – 1,20,17,263 Shares = 1,297.91Crs
QIB – 80,11,769 Shares = 865.27Crs
B-NII (>10L) – 40,05,885 Shares = 432.64Crs
S-NII (2L-10L) – 20,02,942 Shares = 216.32Crs
RII (<2L) – 1,40,20,595 Shares = 1514.22Crs (Lot size: 13 = 10,78,507 Forms)
Total Issue – 4,00,58,844 Shares = 4,326.36Crs.

Mankind Pharma IPO – Schedule *(Tentative)*

18th April – Announcement of Price Band
19th April – Anchor Investors Allotment
21st April – Offer Opens
25th April – Offer Closes
28th April – Finalisation of Basis of Allotment
02nd May – Unblocking of funds from ASBA Account
03rd May – Credit of Equity Shares to Demat accounts
04th May – Commencement of Trading

GMP falling , from 110 to 65 seller now, wait bit and let dust settle

IPO dates not out yet. Is this still happening from 21-25?

Mankind Pharma IPO

GMP 62 +/- 2
Last heard

Interesting quotes on markets
1. Don’t panic “Invest for the long haul. Don’t get too greedy and don’t get too scared.”
Shelby M.C. Davis
2. Crises are normal “If you’re going to invest in stocks for the long term, or real estate, of course, there are going to be periods when there's a lot of agony and other periods when there's a boom. I think you just have to learn to live through them.”
Charlie Munger
3. Downturns are moments of opportunity “I've found that when the market's going down and you buy funds wisely, at some point in the future you will be happy.”
Peter Lynch
4. Your pain is understandable “No matter how calm you are, no matter how long-term an investor you are, no matter what your horizons, when the market is jumping around, you feel uncertainty in your gut and it's hard to resist that.”
Peter Bernstein
5. Control your fear “The most important lesson an investor can learn is to be dispassionate when confronted by unexpected and unfavourable outcomes.”
Peter Bernstein
6. Don’t go into your bunker "The biggest risk of all is not taking one."
Mellody Hobson
7. Ignore the voices of doom “It is always easiest to run with the herd; at times, it can take a deep reservoir of courage and conviction to stand apart from it. Yet distancing yourself from the crowd is an essential component of long-term investment success.”
Seth Klarman
8. The gloom will lift “Your success in investing will depend in part on your character and guts and in part on your ability to realise, at the height of ebullience and the depth of despair alike, that this too, shall pass.”
John Bogle
9. Patience is a virtue “The mantra is patience, patience and more patience. Think long-term and remember that the big rewards accrue with compound annual rates of return.”
Peter Cundill
10. Trust in your long-term plan “The best way to measure your investing success is not by whether you’re beating the market but by whether you’ve put in place a financial plan and a behavioural discipline that are likely to get you where you want to go.”
Benjamin Graham

me to yaha junjun wala ko dhundh raha tha bro..🥲

@arunARUN 
My personal experience of 25 years stock market... none of them really works in isolation... but put together, might be... one needs to take pressure and keep analysing ability always on

88/92

HoS : 58/62

Swinging back up? Heard latest gmp around 68-70.
Is this correct?

Guys I was just analyzing tata tech ipo
I calculated the prize band of around rs 41-43
Can anyone check this